Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).
The presence of norovirus is increasing in Las Vegas area wastewater, according to the Southern Nevada Health District. Though commonly referred to as ...